Article
Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 15 Oct 2003
Havrilesky Laura, Darcy kathleen M, Hamdan Hasnah, Priore Roger L, Leon Jorge, Bell Jeffrey, Berchuck Andrew
Abstract excerpt
PURPOSE: The prognostic significance of p53 mutations and overexpression in advanced epithelial ovarian cancers was examined in primary tumors from 125 patients participating in a Gynecologic Oncology Group randomized phase III treatment protocol. PATIENTS AND METHODS: Mutational analysis of p53 was performed in RNA or genomic DNA extracted from frozen tumor. An immunohistochemistry assay was used to detect p53...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
